BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26490999)

  • 1. Just hypercalcaemia or acute ST elevation myocardial infarction? A review of hypercalcaemia-related electrocardiographic changes.
    Patnaik S; Lai YK
    BMJ Case Rep; 2015 Oct; 2015():. PubMed ID: 26490999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of extreme hypercalcaemia: the role of haemodialysis.
    Basok AB; Rogachev B; Haviv YS; Vorobiov M
    BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29866671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged remission of hypercalcaemia due to parathyroid carcinoma with pamidronate.
    Newrick PG; Braatvedt GD; Webb AJ; Sheffield E; Corrall RJ
    Postgrad Med J; 1994 Mar; 70(821):231-2. PubMed ID: 8183761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combination therapy with pamidronate and calcitonin in hypercalcemic crisis caused by primary hyperparathyroidism].
    Christensen JH; Kristiansen JH
    Ugeskr Laeger; 1992 Nov; 154(47):3341-2. PubMed ID: 1462441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia.
    Ralston SH; Gardner MD; Dryburgh FJ; Jenkins AS; Cowan RA; Boyle IT
    Lancet; 1985 Oct; 2(8461):907-10. PubMed ID: 2865417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The management of hypercalcaemia in advanced cancer.
    Pettifer A; Grant S
    Int J Palliat Nurs; 2013 Jul; 19(7):327-31. PubMed ID: 24273809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of cancer associated hypercalcaemia with combined aminohydroxypropylidene diphosphonate and calcitonin.
    Ralston SH; Alzaid AA; Gardner MD; Boyle IT
    Br Med J (Clin Res Ed); 1986 Jun; 292(6535):1549-50. PubMed ID: 3087513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of hypercalcemia with ibandronate in case of acute renal failure].
    Bergner R; Henrich DM; Hoffmann M; Bruckner D; Uppenkamp M
    Internist (Berl); 2006 Mar; 47(3):293-6. PubMed ID: 16470360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe prolonged hypocalcaemia following pamidronate for malignant hypercalcaemia.
    Sims EC; Rogers PB; Besser GM; Plowman PN
    Clin Oncol (R Coll Radiol); 1998; 10(6):407-9. PubMed ID: 9890546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modern management of malignant hypercalcemia.
    Legrand SB
    Am J Hosp Palliat Care; 2011 Nov; 28(7):515-7. PubMed ID: 21724679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of bisphosphonates to treat severe idiopathic hypercalcaemia in a young Ragdoll cat.
    Whitney JL; Barrs VR; Wilkinson MR; Briscoe KA; Beatty JA
    J Feline Med Surg; 2011 Feb; 13(2):129-34. PubMed ID: 21036642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of acute lymphoblastic leukemia-induced extreme hypercalcemia with pamidronate and calcitonin.
    Mathur M; Sykes JA; Saxena VR; Rao SP; Goldman GM
    Pediatr Crit Care Med; 2003 Apr; 4(2):252-5. PubMed ID: 12749663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term control of hypercalcaemia in an infant with williams-Beuren syndrome after a single infusion of biphosphonate (Pamidronate).
    Oliveri B; Mastaglia SR; Mautalen C; Gravano JC; Pardo Argerich L
    Acta Paediatr; 2004 Jul; 93(7):1002-3. PubMed ID: 15303821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An audit of the management of malignant hypercalcaemia.
    Gerrard GE; Dodwell DJ; Vail A; Watters J; Overend MA
    Clin Oncol (R Coll Radiol); 1996; 8(1):39-42. PubMed ID: 8688360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mismanagement of malignant hypercalcaemia.
    Lightowlers S; Patterson D
    Clin Med (Lond); 2013 Feb; 13(1):118. PubMed ID: 23472518
    [No Abstract]   [Full Text] [Related]  

  • 16. Not all ST-segment changes are myocardial injury: hypercalcaemia-induced ST-segment elevation.
    Strand AO; Aung TT; Agarwal A
    BMJ Case Rep; 2015 Oct; 2015():. PubMed ID: 26464407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Parathyroid crisis due to a cystic parathyroid adenoma].
    Serra Soler G; García Fernández H; Quevedo Juanals J; Argüelles Jiménez I; Carrillo García P
    Endocrinol Nutr; 2011 Mar; 58(3):148-50. PubMed ID: 21345753
    [No Abstract]   [Full Text] [Related]  

  • 18. Severe Hypercalcemia in a Child With Acute Lymphoblastic Leukemia Relapse: Successful Management With Combination of Calcitonin and Bisphosphonate.
    Tagiyev A; Demirbilek H; Tavil B; Buyukyilmaz G; Gumruk F; Cetin M
    J Pediatr Hematol Oncol; 2016 Apr; 38(3):232-4. PubMed ID: 26907650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative tolerability of drug therapies for hypercalcaemia of malignancy.
    Zojer N; Keck AV; Pecherstorfer M
    Drug Saf; 1999 Nov; 21(5):389-406. PubMed ID: 10554053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of resistant hypercalcemia of malignancy with a proposed treatment algorithm.
    McMahan J; Linneman T
    Ann Pharmacother; 2009 Sep; 43(9):1532-8. PubMed ID: 19622757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.